Lung macrophages stop TB relapse by blocking bacterial hiding tricks

Tuberculosis (TB) begins when Mycobacterium tuberculosis (Mtb) reaches the lungs and encounters immune cells there. Alveolar macrophages (AMs) are the first cells to meet Mtb, but they often fail to clear the bacterium, allowing it to persist. Another group of lung immune cells, interstitial macrophages (IMs), are recruited into the lung and have been implicated in restricting Mtb growth and limiting the bacterium’s ability to evade the immune system. Until now, it was not clear whether IMs help keep Mtb in check during latent tuberculosis infection (LTBI) — the stage when people carry Mtb without active disease. Corresponding author Sabine Ehrt and colleagues set out to test whether IMs are needed to maintain latency and prevent reactivation. They used a previously established mouse model of paucibacillary Mtb infection that mimics aspects of LTBI in humans, and they selectively depleted IMs during the latent phase. The study asked a simple question: if IMs are removed during latency, will Mtb reactivate and cause TB relapse?

To examine this, the team applied selective depletion of IMs in their mouse model during the latent phase of infection. When IMs were transiently removed, TB relapse occurred in 26% of mice, compared with only 2% in control animals that kept their IMs. The temporary loss of this macrophage subset also caused short-term changes in other lung immune cells, affecting both pulmonary macrophage and neutrophil populations. Importantly, mice that relapsed showed a shift in the character of IMs toward a more pro-inflammatory profile and had higher concentrations of several signaling molecules in the lung, including G-CSF, GM-CSF, IL3, IL-12, IL-13, IL-17A and KC. These findings come from direct manipulation in the paucibacillary Mtb infection model and indicate that IMs act to contain latent bacteria and limit immune changes that would otherwise favor reactivation.

The results point to a critical role for interstitial macrophages in keeping latent Mtb under control and preventing TB relapse. By showing that removing IMs during latency increased the chance of reactivation, the study highlights how a specific lung cell population helps maintain the balance between dormancy and disease. The observed rise in pro-inflammatory IMs and multiple cytokines in relapsing mice suggests that the cellular and chemical environment in the lung matters greatly: shifts away from IM-mediated containment can permit Mtb to escape and cause active infection. For researchers and clinicians, this work emphasizes that protecting or restoring IM function during or after initial infection could be important for preventing relapse, and that measuring changes in lung immune cells and cytokines may help identify when latency is at risk of failing.